Pegenzileukin

DB17495Investigational

Pegenzileukin: Overview.

Mechanism
Curator reviewed
Also known as
IL-2 variant THOR-707 · Pegylated recombinant interleukin-2 THOR-707
Code names
SAR-444245 · THOR-707

Resolves to

Compound
UNII10WR240QN7CAS2573074-47-0

What you can answer from here — as of August 14, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Pegenzileukin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In